Contribution By Saipriya Iyer
FireEye, the intelligence-led security company has reportedly confirmed the acquisition of Verodin, a leading validator of the effectiveness of cyber security controls. The deal is valued at around $250 million in stock and cash.
The clinical trial comes in collaboration with U.S pharma firm Bristol-Myers Squibb.
The study’s primary endpoint is expected in Q4 2019.
French biopharmaceutical firm, Transgene SA has recently announced that it has enrolled the last pat
The startup is looking to tap into the emerging market of solar plants owing to the increased demand for alternative sources of energy
Alfa Ventures, a proprietary fund introduced by angel investor Dhianu Das, has reportedly announced that it has
Apparently, Fonterra has plans to shut over 100-year old Dennington factory in Australia.
Swiss multinational food and drink firm Nestle SA and multinational dairy company Fonterra Co-operative Group Limited have reportedly announced that they wi
The acquisition will help Thermo Fisher expand its capacity and meet demands for complex APIs.
U.S. biotechnology firm, Thermo Fisher Scientific Inc. has recently announced that it has entered into a definitive agreement with British pharmaceutica
The latest Newport investment has doubled the manufacturing capacity of Santoprene thermoplastic elastomers at the site
ExxonMobil Corporation, the American multinational oil & gas company, has reportedly announced that it has completed the ex
Premiere Packaging Industries, Inc., has recently been acquired by Spicer Paper which is a division of Central National Gottesman Inc. (CNG), one of the world’s largest distributers of paper, pulp, packaging, tissue, plywood and newsprint, expandin
Discussions for acquisition of Mytrah’s renewable power by Piramal and CPPIB have been in fray for some time now.
Piramal group plans to add potential asset of Mytrah’s operational renewable power to the newly launched private firm,
About 400 Takeda employees working on Xiidra and based mostly in Canada and the U.S. will transfer over to Novartis
Reports confirm that Takeda, a research and development-driven pharmaceutical company, is selling Xiidra, a dry eye medication from